Skye Bioscience, Inc. (SKYE): Weighted Average Diluted Shares
39.66M
Year ended 2025-12-31
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 39.66M | +8.7% | 2026-03-10, From 2025-01-01 |
| 2024-12-31 | 36.49M | n/c | 2026-03-10, From 2024-01-01 |
| 2023-12-31 | 7.01M | +215.4% | 2025-03-20, From 2023-01-01 |
| 2022-12-31 | 2.22M | -99.5% | 2024-03-22, From 2022-01-01 |
| 2021-12-31 | 406.60M | +75.7% | 2023-03-31, From 2021-01-01 |
| 2020-12-31 | 231.42M | +36.5% | 2022-03-28, From 2020-01-01 |
| 2019-12-31 | 169.56M | +40.0% | 2021-03-02, From 2019-01-01 |
| 2018-12-31 | 121.15M | +334.2% | 2020-03-23, From 2018-01-01 |
| 2017-12-31 | 27.91M | +47.3% | 2018-03-19, From 2017-01-01 |
| 2016-12-31 | 18.95M | n/a | 2018-03-19, From 2016-01-01 |